Association of Menopausal Status with Pathological Features of Tumor in Stage I to III A Breast Cancer Patients Treated With Upfront Modified Radical Mastectomy

Abstract

Introduction: Breast cancer is the commonest malignancy diagnosed among women worldwide. In Pakistan around 90,000 women are diagnosed with breast cancer every year. Lymphnode involvement, tumor size, receptor status, tumor grade, presence of LVI, age and ethnicity are well recognized prognostic factors for breast cancer. The aim of this study was to evaluate the relationship of menopausal status with pathological and prognostic features of tumor in patients with stage I to III A breast cancer treated upfront with modified radical mastectomy. Material and Methods:This was a single institute observational retrospective study conducted at Nuclear Medicine Oncology and Radiotherapy Institute (NORI) Islamabad. A total of 381 patients with histopathologically proven diagnosis of Invasive ductal carcinoma after modified radical mastectomy were included from January 2009 to December 2013. Age, menopausal status, tumor site, tumor size, grade, lymphnode involvement, receptor status and presence of LVI were recorded on a particularly composed proforma. Statistical analysis for determining the association between menopausal status and pathologic features of tumor was performed using Chi-square test. P value < 0.05 was considered significant. Results:The minimum age of study population was 24 years and maximum age was 80 years with a mean age +/-SD of 48.5 +/-11.1 years. There was a statistically significant association between menopausal status and grade of tumor, lymphovascular invasion and HER2/neuoverexpression (p < 0.05). Conclusion:Grade of tumor, lymphovascular invasion and HER2/neu over expression in stage I to IIIA breast cancer has statistically significant association with menopausal status.

Immunohistochemical Profile of Infiltrating Ductal Carcinoma Breast (Not Otherwise Specified) - A Study Of 100 Cases

“…Studies by Wilking N et al, [32] Faheem M et al, [33] and Mahmood H et al showed similar results. [34] In present study, we did not observe any significant correlation between axillary lymph node status with ER (p value=0.651), PR (p value=0.689) and HER2/neu (p value=0.594) expression in present study. Studies by Ambroise M et al, [19] Azizun Nisa et al, [35] showed similar results.…”

Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark

“…Breast tumors in premenopausal women often have poor prognostic characteristics—higher stage and grade and estrogen receptor (ER) negative [ 16 , 17 ]. Accordingly, most premenopausal women are recommended taxane-based chemotherapy, followed by up to 10 years of tamoxifen therapy for those with ER+ tumors, whereas postmenopausal women to a greater extent can forego chemotherapy [ 18 – 20 ].…”